Rani Therapeutics Holdings, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.57 M | $5.56 M | 100.00% | 8.93% |
VANGUARD GROUP INC | 11/13/2024 | 709,828 | $1.53 M | 0.00% | 2.46% |
NAN FUNG GROUP HOLDINGS LTD | 11/13/2024 | 493,584 | $1.07 M | 0.00% | 1.71% |
ALPHABET INC. | 11/08/2024 | 448,492 | $968,743 | 0.00% | 1.56% |
UNITED SERVICES AUTOMOBILE ASSOCIATION | 11/15/2024 | 302,743 | $653,925 | -3.00% | 1.05% |
STIFEL FINANCIAL CORP | 11/14/2024 | 269,768 | $582,700 | 100.39% | 0.94% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 172,261 | $372,156 | 14.28% | 0.60% |
KING LUTHER CAPITAL MANAGEMENT CORP | 11/08/2024 | 81,129 | $175,239 | 44.54% | 0.28% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 76,145 | $164,474 | -17.09% | 0.26% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 71,500 | $154,440 | 0.00% | 0.25% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 63,583 | $137,339 | 100.00% | 0.22% |
LASRY MARC | 11/14/2024 | 62,887 | $135.84 M | 0.00% | 0.22% |
MOTCO | 11/05/2024 | 48,129 | $103.96 M | 0.00% | 0.17% |
STATE STREET CORP | 11/14/2024 | 42,042 | $90,811 | 0.00% | 0.15% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 33,199 | $71,710 | 52.99% | 0.12% |
BROWN ADVISORY INC | 11/13/2024 | 32,911 | $71,088 | 0.00% | 0.11% |
CITADEL ADVISORS LLC | 11/14/2024 | 26,904 | $58,113 | 82.21% | 0.09% |
LAFAYETTE INVESTMENTS, INC. | 10/22/2024 | 19,893 | $42,969 | 0.00% | 0.07% |
UBS GROUP AG | 11/14/2024 | 15,709 | $33,931 | 423.63% | 0.05% |
PRIME CAPITAL INVESTMENT ADVISORS, LLC | 11/05/2024 | 11,485 | $24,808 | -17.27% | 0.04% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 11,447 | $24,726 | 100.00% | 0.04% |
CERITY PARTNERS LLC | 11/12/2024 | 10,000 | $21,600 | 100.00% | 0.03% |
ISLAY CAPITAL MANAGEMENT, LLC | 11/07/2024 | 9,611 | $20,760 | 0.00% | 0.03% |
MORGAN STANLEY | 11/14/2024 | 5,251 | $11,342 | 77.94% | 0.02% |
ALLWORTH FINANCIAL LP | 10/23/2024 | 3,119 | $6,738 | 0.00% | 0.01% |
SIMPLEX TRADING, LLC | 11/08/2024 | 2,835 | $6,000 | 91.30% | 0.01% |
CITADEL ADVISORS LLC | 11/14/2024 | 2,500 | $5,400 | 25.00% | 0.01% |
CITADEL ADVISORS LLC | 11/14/2024 | 2,200 | $4,752 | -29.03% | 0.01% |
PNC FINANCIAL SERVICES GROUP, INC. | 11/08/2024 | 2,000 | $4,320 | 0.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 1,721 | $3,717 | -88.08% | 0.01% |
JPMORGAN CHASE & CO | 12/26/2024 | 71 | $153 | 0.00% | 0.00% |
RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
MARSHALL WACE, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
VIRTU FINANCIAL LLC | 11/20/2024 | 0 | $0 | -100.00% | 0.00% |
BELVEDERE TRADING LLC | 11/01/2024 | 0 | $0 | -100.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Rani Therapeutics Holdings, Inc.institutional Ownership - FAQ's
During the previous two years, 37 institutional investors and hedge funds held shares of Rani Therapeutics Holdings, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 2.57 M
VANGUARD GROUP INC: 709,828
Nan Fung Group Holdings Ltd: 493,584
Alphabet Inc.: 448,492
UNITED SERVICES AUTOMOBILE ASSOCIATION: 302,743
STIFEL FINANCIAL CORP: 269,768
19.79% of Rani Therapeutics Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.73 M shares in the last 24 months. This purchase volume represents approximately $7.33 M in transactions.